Algeta to Participate in Upcoming Investor Conferences

OSLO, NORWAY--(Marketwired - Aug 12, 2013) - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that
members of
its executive management team will participate in the following
upcoming
investor conferences:

Wedbush Life Sciences Management Access Conference

Date: 13-14 August 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Tuesday 13 August 2013

Venue: New York City, NY, USA

Morgan Stanley Global Healthcare Conference

Date: 9-11 September 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Monday 9 September 2013

Venue: New York City, NY, USA

J.P. Morgan Cazenove London Small/Mid-Cap 1x1 Conference

Date: 11-12 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Venue: London, UK

Bank of America Merrill Lynch Global Healthcare Conference

Date: 11-13 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Friday 13 September 2013

Venue: London, UK

Presentations, where applicable, will be available to download at
www.algeta.com
following these events.

About Algeta

Algeta is a company focused on developing novel targeted therapies for
patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
based in
Cambridge, MA performing commercial marketing operations in the US. Algeta
is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information
please
visit www.algeta.com.